ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
meitheal pharmaceuticals inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp .* (including k. pneumoniae*), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp. ,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients (see precautions-pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp . (including k. pneumoniae *), bacteroides spp . (including b. fragilis ), and enterobacter spp .* gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis *). * efficacy for this organism in this organ system was studied in fewer than 10 infections. while a
ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
eugia us llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp.* (including k. pneumoniae * ), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients (see precautions–pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae * ), bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis * ). * efficacy for this organism in this organ system was studied in
ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
eugia us llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,*klebsiella spp.* (including k. pneumoniae *), proteus mirabilis ,*bacteroides fragilis ,*enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients (see precautions–pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae *), bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis *). * efficacy for this organism in this organ system was studied in fewer than
ampicillin sodium and sulbactam sodium- ampicillin sodium, sulbactam sodium injection, powder, for solution
armas pharmaceuticals inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp.* (including k. pneumoniae* ), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp.,* and acinetobacter calcoaceticus.* note: for information on use in pediatric patients (see precautions– pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae* ), bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli,* and bacteroides spp.* (including b. fragilis* ). * efficacy for this organism in this or
ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
meitheal pharmaceuticals inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp.* (including k. pneumoniae *), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients see precautions-pediatric use and clinical studies sections. intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp . (including k. pneumoniae *), bacteroides spp. (including b. fragilis ), and enterobacter spp. * gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis *). * efficacy for this organism in this organ system was studied in fewer than 10 infections. while ampicil
penibrin 1 g
abic marketing ltd, israel - ampicillin as sodium - powder for solution for inj/inf - ampicillin as sodium 1 g/vial - ampicillin - ampicillin - penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.
penibrin 2 g
abic marketing ltd, israel - ampicillin as sodium - powder for solution for inj/inf - ampicillin as sodium 2 g/vial - ampicillin - ampicillin - penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.
penibrin 500 mg
abic marketing ltd, israel - ampicillin as sodium - powder for solution for inj/inf - ampicillin as sodium 500 mg/vial - ampicillin - ampicillin - penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection.such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.
unasyn 1.5 g.
pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - powder for solution for injection - ampicillin as sodium 1000 mg; sulbactam as sodium 500 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.
unasyn 3 g.
pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - powder for solution for injection - ampicillin as sodium 2000 mg; sulbactam as sodium 1000 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.